Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Clinical Endocrinology

• Publication date

  2004-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1365-2265.2003.01918.xPMID 15008994
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Management of simple nodular goiter: current status and future perspectives.

  2003cited by this paper
• Thyroid Microcarcinoma: Fine-Needle Aspiration Diagnosis and Histologic Follow-up

  2002cited by this paper
• Does Radioiodine Therapy Have an Equal Effect on Substernal and Cervical Goiter Volumes? Evaluation by Magnetic Resonance Imaging

  2002cited by this paper
• MR imaging of large multinodular goiters: observer agreement on volume versus observer disagreement on dimensions of the involved trachea.

  2002cited by this paper
• Ultrasonography in the diagnosis of cancer in multinodular goiter

  2002cited by this paper
• Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism.

  2002cited by this paper
• Pretreatment with recombinant human TSH changes the regional distribution of radioiodine on thyroid scintigrams of nodular goiters.

  2001cited by this paper
• [Subclinical hyperthyroidism ].

  2001cited by this paper
• Evaluation and treatment of sporadic nontoxic goiter--some answers and more questions.

  2001cited by this paper
• A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter.

  2001cited by this paper
• The Various Effects of Amiodarone on Thyroid Function

  2001cited by this paper
• Searching for Iodine Deficiency Disorders in Schoolchildren from Brazil: The Thyromobil Project

  2001influential reference
• Practical application of recombinant thyrotropin testing in clinical practice.

  2001cited by this paper
• Clinical practice. Subclinical hyperthyroidism.

  2001cited by this paper
• Hyperthyroid heart disease

  2000cited by this paper
• Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodide uptake in nontoxic nodular goiter.

  2000cited by this paper
• Compassionate use of recombinant human thyrotropin to facilitate radioiodine therapy: case report and review of literature.

  2000cited by this paper
• The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function.

  1999cited by this paper
• Treatment of benign nodular thyroid disease.

  1998cited by this paper
• Cardiac Risks of Hyperthyroidism in the Elderly

  1998cited by this paper
• Recombinant human thyrotropin is a potent stimulator of thyroid function in normal subjects.

  1997cited by this paper
• Outpatient management of patients with large multinodular goitres treated with fractionated radioiodine

  1997cited by this paper
• Thyroid volume and function after 131I treatment of diffuse non‐toxic goitre

  1997cited by this paper
• Serum TSH and the response to radioiodine treatment of toxic multinodular goitre.

  1997cited by this paper
• Reduction in goiter size by 131I therapy in patients with non-toxic multinodular goiter.

  1995cited by this paper
• The aging thyroid.

  1995cited by this paper
• Acute changes in thyroid volume and function following 131I therapy of multinodular goitre

  1994cited by this paper
• Large, Compressive Goiters Treated with Radioiodine

  1994cited by this paper
• Radioiodine treatment of multinodular non-toxic goitre.

  1993cited by this paper
• Two Simple Methods for Measuring Iodine in Urine

  1993cited by this paper
• Radioiodine therapy in voluminous multinodular non-toxic goitre.

  1990cited by this paper
• Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter.

  1990cited by this paper
• Reduction of size of thyroid with radioactive iodine in multinodular non-toxic goitre.

  1988cited by this paper
• Treatment of non-toxic multinodular goiter with radioactive iodine.

  1988cited by this paper
• Direct toxic effect of iodide in excess on iodine-deficient thyroid glands: epithelial necrosis and inflammation associated with lipofuscin accumulation.

  1986cited by this paper
• Hyperthyroid heart disease.

  1968cited by this paper

• Efficacy of Microwave Ablation in the Treatment of Hyperthyroidism With Benign/Malignant Nodules.

  2025cites this paper
• The EANM guideline on radioiodine therapy of benign thyroid disease

  2023cites this paper
• Non-Toxic Multinodular Goiter: From Etiopathogenesis to Treatment

  2022cites this paper
• Recombinant human thyrotropin (rhTSH)-aided radioiodine treatment for non-toxic multinodular goitre.

  2021cites this paper
• Recombinant Human Thyrotropin-Stimulated Radioiodine Therapy in Patients with Multinodular Goiters: A Meta-Analysis of Randomized Controlled Trials

  2020cites this paper
• Radioiodine Therapy for Benign Thyroid Disease

  2020cites this paper
• Iodine 131 in the treatment of large goiters

  2020cites this paper
• Graves' disease, multinodular goiter and subclinical hyperthyroidism.

  2019cites this paper
• Thyroid Nodule: Current Evaluation and Management

  2019cites this paper
• Radioiodine Therapy of Benign Thyroid Diseases

  2019cites this paper
• Nontoxic Multinodular Goiter

  2019cites this paper
• Radioiodine in the Management of Benign Thyroid Disease

  2018cites this paper
• Treatment options of subclinical hyperthyroidism and cardiovascular risk

  2018cites this paper
• Radioiodtherapie bei benignen Schilddrüsenerkrankungen (Version

  2017cites this paper
• Chapter 90 – Multinodular Goiter

  2016cites this paper
• Radioiodtherapie bei benignen Schilddrüsenerkrankungen (Version 5)*

  2016cites this paper
• Single, very low dose (0.03 mg) of recombinant human thyrotropin (rhTSH) effectively increases radioiodine uptake in the I-131 treatment of large nontoxic multinodular goiter.

  2016cites this paper
• [Radioiodine therapy for benign thyroid diseases (version 5). German Guideline].

  2016cites this paper
• Recombinant human thyrotropin stimulated 131I treatment for multinodular goiter

  2016influential citation
• THYROIDMANAGER . ORG CHAPTER 17 – MULTINODULAR GOITER

  2016influential citation
• A rare presentation of a large goiter with papillary thyroid microcarcinoma as a chest wall mass: A case report.

  2016cites this paper
• AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND MANAGEMENT OF THYROID NODULES--2016 UPDATE.

  2016cites this paper
• AACE/ACE/AME Guidelines AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND MANAGEMENT OF THYROID NODULES – 2016 UPDATE APPENDIX

  2016cites this paper
• Recombinant human thyrotropin before 131I therapy in patients with nodular goitre: a meta‐analysis of randomized controlled trials

  2015cites this paper
• Thiamazole Pretreatment Lowers the (131)I Activity Needed to Cure Hyperthyroidism in Patients With Nodular Goiter.

  2015cites this paper
• The role of radioiodine therapy in benign nodular goitre.

  2014cites this paper
• Long-Term Efficacy of Modified-Release Recombinant Human Thyrotropin Augmented Radioiodine Therapy for Benign Multinodular Goiter: Results from a Multicenter, International, Randomized, Placebo-Controlled, Dose-Selection Study

  2014cites this paper
• Recombinant human TSH and radioactive iodine therapy in the management of benign multinodular goiter.

  2014cites this paper
• Long-term outcome after radioiodine therapy with adjuvant rhTSH treatment: comparison between patients with non-toxic and pre-toxic large multinodular goitre

  2014cites this paper
• Therapy of endocrine disease: treatment of malignant pheochromocytoma and paraganglioma.

  2014cites this paper
• Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for non‐toxic multinodular goitre

  2013cites this paper
• Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome.

  2012cites this paper
• Prestimulation with recombinant human thyrotropin (rhTSH) improves the long-term outcome of radioiodine therapy for multinodular nontoxic goiter.

  2012cites this paper
• Radioiodine Therapy of Hyperthyroidism (Toxic Goiter, Hyperfunctioning Nodule) and Non-Toxic Goiter: Procedures and Guidelines

  2012cites this paper
• Approach to and treatment of goiters.

  2012cites this paper
• Radioiodine 131I Treatment for Large Nodular Goiter: Recombinant Human Thyrotropin Allows the Reduction of Radioiodine 131I Activity to Be Administered in Patients with Low Uptake

  2011cites this paper
• Approach to the patient with nontoxic multinodular goiter.

  2011cites this paper
• Serum thyroxine and age--rather than thyroid volume and serum TSH--are determinants of the thyroid radioiodine uptake in patients with nodular goiter.

  2011cites this paper
• Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study.

  2011cites this paper
• MODIFIED-RELEASE RECOMBINANT HUMAN TSH AUGMENTS THE EFFECT OF 131 I THERAPY IN BENIGN MULTINODULAR GOITER

  2011cites this paper
• Serum thyroxine and age — rather than thyroid volume and serum TSH — are determinants of the thyroid radioiodine uptake in patients with nodular goiter

  2011cites this paper
• Non-surgical approach to the benign nodular goiter: new opportunities by recombinant human TSH-stimulated 131I-therapy

  2011cites this paper
• Modified-Release Recombinant Human TSH (MRrhTSH) Augments the Effect of 131I Therapy in Benign Multinodular Goiter: Results from a Multicenter International, Randomized, Placebo-Controlled Study

  2011cites this paper
• Radioiodine therapy of benign non-toxic goitre. Potential role of recombinant human TSH.

  2011cites this paper
• Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy.

  2010cites this paper
• American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and EuropeanThyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules.

  2010cites this paper
• AACE / AME / ETA Guidelines AMERICAN ASSOCIATION Of ClINICAl ENDOCRINOlOgISTS , ASSOCIAzIONE MEDICI ENDOCRINOlOgI , AND EuROPEAN ThyROID ASSOCIATION MEDICAl guIDElINES fOR ClINICAl PRACTICE fOR ThE DIAgNOSIS AND MANAgEMENT Of ThyROID NODulES

  2010cites this paper
• Dose‐dependent acute effects of recombinant human TSH (rhTSH) on thyroid size and function: comparison of 0·1, 0·3 and 0·9 mg of rhTSH

  2010cites this paper
• Development of Graves' Disease Following a Radioiodine Dose for the Shrinkage of a Multinodular Goiter After Using a Novel Protocol

  2010cites this paper
• Superior Vena Cava Syndrome and Substernal Goiter

  2010cites this paper
• AACE / AME / ETA Guidelines AMERICAN ASSOCIATION Of ClINICAl ENDOCRINOlOgISTS , ASSOCIAzIONE MEDICI ENDOCRINOlOgI , AND EuROPEAN ThyROID ASSOCIATION MEDICAl guIDElINES fOR ClINICAl PRACTICE fOR ThE DIAgNOSIS AND MANAgEMENT Of ThyROID NODulES

  2010cites this paper
• EANM procedure guidelines for therapy of benign thyroid disease

  2010cites this paper
• Stability of Recombinant Human Thyrotropin Potency Based on Bioassay in FRTL-5 Cells

  2010cites this paper
• Role of recombinant human TSH in the management of large euthyroid multinodular goitre: a new therapeutic option? Pros and cons.

  2010cites this paper
• Radioiodine plus recombinant human thyrotropin do not cause acute airway compression and are effective in reducing multinodular goiter.

  2010cites this paper
• Therapy of large multinodular goitre using repeated doses of radioiodine

  2009cites this paper
• Radioiodine - an attractive alternative to surgery in large non-toxic multinodular goitres.

  2009cites this paper
• Latin American thyroid society recommendations for the management of thyroid nodules.

  2009cites this paper
• Radioiodine treatment for non-toxic goitre

  2009cites this paper
• Long-term outcome of low-activity radioiodine administration preceded by adjuvant recombinant human TSH pretreatment in elderly subjects with multinodular goiter

  2009influential citation
• A 30-year perspective on radioiodine therapy of benign nontoxic multinodular goiter*

  2009cites this paper
• Recombinant human TSH increases the efficacy of a fixed activity of radioiodine for treatment of multinodular goitre

  2009cites this paper
• Optimizing 131I Uptake After rhTSH Stimulation in Patients with Nontoxic Multinodular Goiter: Evidence from a Prospective, Randomized, Double-Blind Study

  2009cites this paper
• Time to reconsider nonsurgical therapy of benign non-toxic multinodular goitre: focus on recombinant human TSH augmented radioiodine therapy.

  2009influential citation
• High Prevalence of Side Effects After Recombinant Human Thyrotropin–Stimulated Radioiodine Treatment with 30 mCi in Patients with Multinodular Goiter and Subclinical/Clinical Hyperthyroidism

  2009influential citation
• Administração prévia do TSH humano recombinante, em diferentes doses, no tratamento do bócio multinodular com iodo radioativo: um estudo randomizado, duplo cego, controlado com placebo

  2009cites this paper
• Toxic Nodular Goiter

  2009cites this paper
• [A decade of recombinant human thyrotropin].

  2009cites this paper
• Current and emerging treatment options for Graves’ hyperthyroidism

  2009cites this paper
• An outline concerning the potential use of recombinant human thyrotropin for improving radioiodine therapy of multinodular goiter

  2008cites this paper
• Review on the Occasion of a Decade of Recombinant Human TSH: Prospects and Novel Uses

  2008cites this paper
• Evaluation of various doses of recombinant human thyrotropin in patients with multinodular goiters.

  2008cites this paper
• Recombinant human thyrotropin in the management of thyroid disorders.

  2008cites this paper
• Disnea y estridor en paciente obesa por bocio multinodular

  2008cites this paper
• Recombinant human thyrotropin administration enhances thyroid uptake of radioactive iodine in hyperthyroid cats.

  2008cites this paper
• Dyspnea and stridor due to multinodular goiter in an obese woman.

  2008cites this paper
• Modular Goiter: Results of Prospective Countroled Studies

  2008cites this paper
• Recombinant human thyrotropin in the management of thyroid disorders

  2008cites this paper
• Thiamazole as an adjuvant to radioiodine for volume reduction of multinodular goiter

  2008cites this paper
• Multinodular goiter-diagnostic and treatment considerations

  2008cites this paper
• Recombinant human thyrotropin-stimulated radioiodine therapy of large nodular goiters facilitates tracheal decompression and improves inspiration.

  2008cites this paper
• Expanding use of recombinant hTSH.

  2007cites this paper
• Effect of 30 mCi radioiodine on multinodular goiter previously treated with recombinant human thyroid-stimulating hormone.

  2007cites this paper
• Radioiodine treatment for benign thyroid diseases

  2007cites this paper
• Peripheral blood levels of thyroglobulin mRNA and serum thyroglobulin concentrations after radioiodine ablation of multinodular goiter with or without pre-treatment with recombinant human thyrotropin

  2007cites this paper
• Cardiovascular assessment of hyperthyroid patients with multinodular goiter before and after radioiodine treatment preceded by stimulation with recombinant human TSH

  2007cites this paper
• [The treatment of multinodular large non-toxic goiter using repeated doses of radioiodine (preliminary report)].

  2007cites this paper
• Comparison and Contrast of Surgical and Medical Treatment for Adult Patients (age 20 and older) with Multinodular Goiter

  2007influential citation
• Improvement of goiter volume reduction after 0.3 mg recombinant human thyrotropin-stimulated radioiodine therapy in patients with a very large goiter: a double-blinded, randomized trial.

  2007cites this paper
• Radioiodine in the management of benign thyroid disease: clinical guidelines. Report of a Working Party, 2007. Royal College of Physicians (RCP)

  2007cites this paper
• Transient Goiter Enlargement after Administration of 0.3 mg of Recombinant Human Thyrotropin in Patients with Benign Nontoxic Nodular Goiter: A Randomized, Double-Blind, Crossover TrialNielsen VE, Bonnema SJ, Hegedüs L (Odense Univ, Denmark) J Clin Endocrinol Metab 91:1317–1322, 2006§

  2007cites this paper
• Benign thyroid disease: what is the role of nuclear medicine?

  2006cites this paper
• Use of recombinant human thyroid-stimulating hormone in the management of well-differentiated thyroid cancer

  2006cites this paper
• Prolonged follow‐up of multinodular goitre patients treated with radioiodine preceded or not by human recombinant TSH

  2006cites this paper
• Therapiekonzepte der euthyreoten Struma nodosa: Radioiodtherapie als attraktive Alternative zur Operation

  2006cites this paper
• 123I thyroid uptake and thyroid size at 24, 48, and 72 hours after the administration of recombinant human thyroid-stimulating hormone to normal volunteers.

  2006cites this paper
• Low-dose recombinant human thyrotropin-aided radioiodine treatment of large, multinodular goiters in elderly patients.

  2006cites this paper
• Transient goiter enlargement after administration of 0.3 mg of recombinant human thyrotropin in patients with benign nontoxic nodular goiter: a randomized, double-blind, crossover trial.

  2006cites this paper
• Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign nontoxic nodular goiter: a prospective randomized double-blind trial.

  2006cites this paper
• Therapy for non-toxic multinodular goiter

  2006cites this paper